CHRONIC INFLAMMATION IN DIALYSIS PATIENTS AND ITS CORRELATION WITH DERMATOLOGICAL MANIFESTATIONS: A MULTICENTER STUDY FROM SKOPJE
Keywords:
Chronic systemic inflammation, Dermatological manifestations in dialysis, Haemodialysis patients, Pruritus and xerosis, Inflammatory biomarkersAbstract
Introduction: Chronic systemic inflammation is a defining feature in dialysis patients, contributing significantly to dermatological manifestations such as pruritus, xerosis, pigmentation changes, and nail abnormalities. These conditions impair quality of life and are linked to markers of systemic inflammation and dialysis-related factors.
Objectives: This study aimed to analyze the prevalence and severity of dermatological manifestations in dialysis patients, and their correlations with systemic inflammation.
Methods: An observational, cross-sectional study was conducted in two dialysis centers in Skopje, North Macedonia, involving 167 chronic dialysis patients. Data collection included dermatological assessments, laboratory markers (e.g., CRP, PTH, MPV), and pharmacological histories. Statistical analyses were used to explore correlations.
Results: Pruritus was observed in 74% of patients and correlated significantly with CRP (R=0.223, p=0.005) and PTH (R=0.219, p=0.008). Xerosis affected 88.62% of patients, with moderate severity in 38.92%, and correlated with CRP (R=0.215, p=0.003). Pigmentation changes (63.47%) were linked to MPV (R=0.219, p=0.004), while nail abnormalities (81.44%) correlated with ferritin (R=0.170, p=0.028).
Conclusion: Dermatological manifestations are prevalent in dialysis patients and closely associated with systemic inflammation markers. A multidisciplinary approach is essential to improve management and patient outcomes.
References
GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3.
Stenvinkel P, Heimbürger O, Paultre F, et al. Inflammation in end stage renal disease: The hidden enemy. Nephrol Dial Transplant. 2005;20(4):243–9. doi:10.1093/ndt/gfh711
Dohcheva Karajovanov I, Nikolovska S, Damevska K, Rambabova Bushljetikj I, Dohchev S, Spasovski G. Muco cutaneous changes/symptoms in patients with stage 5 chronic kidney disease on haemodialysis. BANTAO J. 2022;20(2):45–52.
Szepietowski JC, Schwartz RA, Uitto J. Pruritus and skin changes in dialysis patients. Am J Nephrol. 2004;24(6):868–73. doi:10.1159/000081069
Arriaga Escamilla D, Lakhani A, Antony S, et al. Dermatological manifestations in patients with chronic kidney disease: A review. Cureus. 2024;16:e52253. doi:10.7759/cureus.52253
Shariati A, Jahromi MK, Kazemi M, et al. The effects of hemodialysis on quality of life in Iranian patients: A systematic review and meta-analysis. Health Qual Life Outcomes. 2020;18:366. doi:10.1186/s12955 020 01529 7
Stigant CE, Djurdjev O, Levin A. C Reactive Protein Levels in Patients on Maintenance Hemodialysis: Reliability and Reflection on the Utility of Single Measurements. Int Urol Nephrol. 2005;37(2):133–40. doi:10.1007/s11255 004 2359 y
Bramania PK, Ruggajo P, Bramania R, et al. Prevalence of malnutrition inflammation complex syndrome among patients on maintenance haemodialysis at Muhimbili National Hospital in Tanzania: A cross sectional study. BMC Nephrol. 2020;21:521. doi:10.1186/s12882 020 02171 3
Al Jabi SW, Rajabi NS, Koni AA, et al. A multicenter descriptive analysis of anemia management in hemodialysis patients and its association with quality of life. BMC Nephrol. 2023;24:197. doi:10.1186/s12882 023 03254 7
Cozzolino M, Mangano M, Stucchi A, et al. Cardiovascular disease in dialysis patients. Nephrol Dial Transplant. 2018;33(suppl_3):iii28–iii34. doi:10.1093/ndt/gfy174
Swamy S, Noor SM, Mathew RO. Cardiovascular Disease in Diabetes and Chronic Kidney Disease. J Clin Med. 2023;12(22):6984. doi:10.3390/jcm12226984
Van de Velde Kossmann KM. Recognizing Common Skin and Soft Tissue Infections in the Nephrology Clinic. Blood Purif. 2019;47(1–3):259–64. doi:10.1159/000496203
Jeswani J, Bhardwaj A, Bhatt S. Correlation of Cutaneous Manifestations with the Severity of Disease in Patients with Chronic Kidney Disease and Effect of Hemodialysis: An Observational Study. Dermatol AMJ. 2024;1:52–62. doi:10.33590/dermatolamj/HZSA8667
Usman MS, Khan MS, Butler J. The Interplay Between Diabetes, Cardiovascular Disease, and Kidney Disease. ADA Clin Compendia. 2021;2021(1):13–8. doi:10.2337/db20211 13
Bilen Y, Cankaya E, Keles M, et al. Does decreased mean platelet volume predict inflammation in chronic renal failure, dialysis, and transplanted patients? Ren Fail. 2014;36(1):69–72. doi:10.3109/0886022X.2013.832310
Chen HY, Chiu YL, Hsu SP, et al. Elevated C reactive protein level in hemodialysis patients with moderate/severe uremic pruritus: a potential mediator of high overall mortality. QJM. 2010;103(11):837–46. doi:10.1093/qjmed/hcq036
Ruiz Ortega M, Rupérez M, Esteban V, et al. Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant. 2006;21(1):16–20. doi:10.1093/ndt/gfi265
Satou R, Penrose H, Navar LG. Inflammation as a Regulator of the Renin Angiotensin System and Blood Pressure. Curr Hypertens Rep. 2018;20:100. doi:10.1007/s11906 018 0900 0
Kechichian E, Ezzedine K. Vitamin D and the Skin: An Update for Dermatologists. Am J Clin Dermatol. 2018;19(2):223–35. doi:10.1007/s40257 017 0323 8
Derry S, Wiffen PJ, Moore RA, et al. Oral nonsteroidal anti inflammatory drugs (NSAIDs) for cancer pain in adults. Cochrane Database Syst Rev. 2017;7:
Combs SA, Teixeira JP, Germain MJ. Pruritus in Kidney Disease. Semin Nephrol. 2015;35(4):383–91. doi:10.1016/j.semnephrol.2015.06.010
Udayakumar P, Balasubramanian S, Ramalingam KS, et al. Cutaneous manifestations in patients with chronic renal failure on hemodialysis. Indian J Dermatol Venereol Leprol. 2006;72(2):119–25. doi:10.4103/0378 6323.25636
Yao Q, Axelsson J, Stenvinkel P, et al. Chronic systemic inflammation in dialysis patients: an update on causes and consequences. ASAIO J. 2004;50(6):lii–lv. doi:10.1097/01.mat.0000147958.87989.eb
Memoli B, Postiglione L, Cianciaruso B, et al. Role of different dialysis membranes in the release of interleukin 6 soluble receptor in uremic patients. Kidney Int. 2000;58(1):417–24.
Svensson M, Yu ZW, Eriksson JW. A small reduction in glomerular filtration is accompanied by insulin resistance in type 1 diabetes mellitus patients with diabetic nephropathy. Eur J Clin Invest. 2002;32(2):100–9. doi:10.1046/j.1365 2362.2002.00900.x
Bemelmans MH, Gouma DJ, Buurman WA. Influence of nephrectomy on tumor necrosis factor clearance in murine model. J Immunol. 1993;150(5):2007–17. doi:10.4049/jimmunol.150.5.2007
Poole S, Bird TA, Selkirk S, et al. Fate of injected interleukin 1 in rats: Sequestration and degradation in the kidney. Cytokine. 1990;2(5):416–22. doi:10.1016/1043 4666(90)90042 F
Bolton CH, Downs LG, Victory JGG, et al. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro inflammatory cytokines. Nephrol Dial Transplant. 2001;16(6):1189–97. doi:10.1093/ndt/16.6.1189
• Lin CJ, Wu V, Wu PC, et al. Meta analysis of the associations of p cresyl sulfate (PCS) and indoxyl sulfate (IS) with cardiovascular events and all cause mortality in patients with chronic renal failure. PLoS One. 2015;10(7):e0132589. doi:10.1371/journal.pone.0132589
Yamamoto S. Molecular mechanisms underlying uremic toxin related systemic disorders in chronic kidney disease: focused on β2 microglobulin related amyloidosis and indoxyl sulfate induced atherosclerosis—Oshima Award Address 2016. Clin Exp Nephrol. 2019;23(2):151–7. doi:10.1007/s10157 018 1588 9
Ko MJ, Wu HY, Chen HY, et al. Uremic pruritus, dialysis adequacy, and metabolic profiles in hemodialysis patients: a prospective 5 year cohort study. PLoS One. 2013;8(8):e71404. doi:10.1371/journal.pone.0071404
Gherghina ME, Peride I, Tiglis M, et al. Uric acid and oxidative stress—Relationship with cardiovascular, metabolic, and renal impairment. Int J Mol Sci. 2022;23(6):3188. doi:10.3390/ijms23063188
De Deyn PP, D’Hooge R, Vanholder R, et al. Endogenous guanidino compounds as uremic neurotoxins. Kidney Int. 2001;59(suppl 77):S77–83. doi:10.1046/j.1523 1755.2001.59780077.x
Liabeuf S, Pepin M, Franssen CFM, et al. Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle? Nephrol Dial Transplant. 2022;37(suppl 2):ii33–ii44. doi:10.1093/ndt/gfab223
Goodman WG. Medical management of secondary hyperparathyroidism in chronic renal failure. Nephrol Dial Transplant. 2003;18(suppl 3):iii2–8. doi:10.1093/ndt/gfg1002
BMJ Best Practice. Secondary hyperparathyroidism in chronic kidney disease. BMJ Best Practice. Accessed 16 Dec 2024.
Liu D, Fang C, Wang J, et al. Association between homocysteine levels and mortality in CVD: a cohort study based on NHANES database. BMC Cardiovasc Disord. 2024;24:652. doi:10.1186/s12872 024 04317 9
Tian D, Qin Q, Li M, et al. Homocysteine impairs endothelial cell barrier function and angiogenic potential via the progranulin/EphA2 pathway. Front Pharmacol. 2021;11:614760. doi:10.3389/fphar.2020.614760
Tian D, Qin Q, Li M, et al. Homocysteine impairs endothelial cell barrier function and angiogenic potential via the progranulin/EphA2 pathway. Front Pharmacol. 2021;11:614760. doi:10.3389/fphar.2020.614760
Jang YH, Kim SM, Eun DH, Park KD, Park GH, Kim BS, et al. Validity and reliability of itch assessment scales for chronic pruritus in adults: A prospective multicenter study. J Am Acad Dermatol. 2020;82(1):80–6. doi:10.1016/j.jaad.2019.06.043
Augustin M, Wilsmann Theis D, Körber A, Kerscher M, Itschert G, Dippel M, Staubach P. Diagnosis and treatment of xerosis cutis – a position paper. JDDG J Deutsch Derm Gesell. 2019;17:3–33.
Sławińska M, Żółkiewicz J, Behera B, et al. Dermoscopy of Inflammatory Dermatoses (Inflammoscopy) in Skin of Color – A Systematic Review by the International Dermoscopy Society “Imaging in Skin of Color” Task Force. Dermatol Pract Concept. 2023;13(4 Suppl 1). doi:10.5826/dpc.1304S1a297S
Enechukwu NA, Behera B, Ding DD, Lallas A, Chauhan P, Khare S, et al. Dermoscopy of Cutaneous Neoplasms in Skin of Color – A Systematic Review by the International Dermoscopy Society “Imaging in Skin of Color” Task Force. Dermatol Pract Concept. 2023;13(4 Suppl 1). doi:10.5826/dpc.1304S1a308S
Starace M, Alessandrini A, Piraccini BM. Dermoscopy of the Nail Unit. Dermatol Clin. 2021;39(2):293–304. doi:10.1016/j.det.2020.12.008
